Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.47 |
| ▸ | NPC1 | O15118 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 5/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | PKM | P14618 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.47 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.45 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.45 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.45 |
| ▸ | GRM4 | Q14833 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19668773 | 0.79 | ALDH1A1 (0.46) | ALDH1A1CES2CES1SMN1; SMN2NPC1 | |
| SCHEMBL504660 | 0.79 | ALDH1A1 (0.46) | ALDH1A1CES2CES1SMN1; SMN2NPC1 | |
| SCHEMBL5640995 | 0.78 | ALDH1A1 (0.54) | ALDH1A1CES2CES1SMN1; SMN2NPC1 | |
| Hydrochloric Acid SCHEMBL4430965 | 0.77 | KDM4E (0.44) | ALDH1A1CES2CES1SMN1; SMN2NPC1 | |
| Hydrochloric Acid SCHEMBL5450983 | 0.77 | KDM4E (0.44) | ALDH1A1CES2CES1SMN1; SMN2NPC1 | |
| SCHEMBL4378933 | 0.77 | ALDH1A1 (0.57) | ALDH1A1CES2CES1SMN1; SMN2NPC1 | |
| SCHEMBL22653498 | 0.76 | ALDH1A1 (0.43) | ALDH1A1CES2CES1SMN1; SMN2NPC1 | |
| SCHEMBL30314230 | 0.76 | ALDH1A1 (0.43) | ALDH1A1CES2CES1SMN1; SMN2NPC1 | |
| SCHEMBL14114235 | 0.76 | MEN1 (0.42) | ALDH1A1SMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL6006624 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5062 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025078932-A1 | A PROCESS FOR SELECTIVE DIMETHYL CARBONATE (DMC) SYNTHESIS AND A SYSTEM THEREOF | RELIANCE INDUSTRIES LIMITED (IN) | 2025-04-17 | — | — | WO | claimed |
| WO-2025078933-A1 | A PROCESS FOR SELECTIVE DIMETHYL CARBONATE (DMC) SYNTHESIS AND A SYSTEM THEREOF | RELIANCE INDUSTRIES LIMITED (IN) | 2025-04-17 | — | — | WO | claimed |
| EP-1797123-B1 | COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE | UNIV LIEGE (BE) | 2010-03-03 | — | — | EP | claimed |
| EP-4748862-A2 | HETERODIMERIC PROTEINS | Xencor, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-3620473-B1 | NOVEL HETERODIMERIC PROTEINS | XENCOR INC (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-3865514-B9 | BISPECIFIC ANTIBODY BINDING DLL3 AND CD3 | AMGEN RES MUNICH GMBH (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-12630650-B2 | Engineered IgA antibodies and methods of use | TIGATX, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260132199-A1 | ANTIBODY CONSTRUCTS FOR DLL3 AND CD3 | AMGEN RES MUNICH GMBH (DE) | 2026-05-14 | — | — | US | disclosed |
| EP-4741424-A2 | FC VARIANTS WITH ALTERED BINDING TO FCRN | Xencor, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-3817770-B1 | ANTI-STEAP1 ANTIGEN-BINDING PROTEIN | AMGEN INC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12617853-B2 | Low pH pharmaceutical composition comprising T cell engaging antibody constructs | Amgen Research (Munich), GmbH (DE) | 2026-05-05 | — | — | US | disclosed |
| EP-0072121-A1 | Beta-lactam antibiotics | BEECHAM GROUP PLC (GB) | 1983-02-16 | — | — | EP | disclosed |
| US-4335043-A | Substituted N-methylene derivatives of thienamycin | MERCK & CO., INC. (US) | 1982-06-15 | — | — | US | disclosed |
| US-4232030-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1980-11-04 | — | — | US | disclosed |
| US-4194047-A | Substituted N-methylene derivatives of thienamycin | MERCK & CO., INC. (US) | 1980-03-18 | — | — | US | disclosed |
| EP-0001264-A1 | Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone and their preparation | MERCK & CO. INC. (US) | 1979-04-04 | — | — | EP | disclosed |
| US-4073783-A | PENICILLINS | PFIZER INC. (US) | 1978-02-14 | — | — | US | disclosed |
| US-4025506-A | PENICILLINS | PFIZER INC. (US) | 1977-05-24 | — | — | US | disclosed |
| US-4025504-A | PENICILLINS | PFIZER INC. (US) | 1977-05-24 | — | — | US | disclosed |
| US-3951952-A | 6-(ALPHA-(AMIDINO-AND IMIDOYLAMINOALKANOYLAMINO)ARACYLAMINO)-PENICILLANIC ACIDS | PFIZER INC. (US) | 1976-04-20 | — | — | US | disclosed |